This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Amyris Future Growth

Future criteria checks 2/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Amyris.

Key information

46.4%

Earnings growth rate

50.4%

EPS growth rate

Chemicals earnings growth50.2%
Revenue growth rate21.3%
Future return on equityn/a
Analyst coverage

Low

Last updated14 Aug 2023

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BOVESPA:A2MR34 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025592-154-30-172
12/31/2024473-237-70-1242
12/31/2023507-298-98-1362
3/31/2023268-615-540-463N/A
12/31/2022270-529-632-526N/A
9/30/2022259-341-700-575N/A
6/30/2022236-213-623-511N/A
3/31/2022223-89-519-442N/A
12/31/2021342-270-227-181N/A
9/30/2021357-417-74-49N/A
6/30/2021343-467-48-35N/A
3/31/2021321-585-35-21N/A
12/31/2020173-382-189-176N/A
9/30/2020134-351-223-209N/A
6/30/2020135-325-222-209N/A
3/31/2020167-293-177-166N/A
12/31/2019153-270-170-157N/A
9/30/2019128-240-149-133N/A
6/30/2019108-258-127-113N/A
3/31/201960-202-135-121N/A
12/31/201864-223-122-109N/A
9/30/2018112-287-98-88N/A
6/30/2018122-253-104-95N/A
3/31/2018133-250-106-101N/A
12/31/2017128-202-106-101N/A
9/30/201785-139-140-140N/A
6/30/201787-116-104-104N/A
3/31/201771-119-85-84N/A
12/31/201667-97N/A-82N/A
9/30/201655-94N/A-78N/A
6/30/201637-151N/A-91N/A
3/31/201635-185N/A-106N/A
12/31/201534-222N/A-85N/A
9/30/201536-118N/A-73N/A
6/30/201544-78N/A-82N/A
3/31/201545-66N/A-78N/A
12/31/2014432N/A-85N/A
9/30/201447-195N/A-101N/A
6/30/201438-183N/A-96N/A
3/31/201439-186N/A-92N/A
12/31/201341-235N/A-106N/A
9/30/201332-139N/A-101N/A
6/30/201344-135N/A-105N/A
3/31/201352-143N/A-113N/A
12/31/201274-205N/A-151N/A
9/30/2012109-221N/A-146N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A2MR34 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: A2MR34 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: A2MR34 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: A2MR34's revenue (21.3% per year) is forecast to grow faster than the BR market (7.1% per year).

High Growth Revenue: A2MR34's revenue (21.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if A2MR34's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.